Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Stabilized gonadotropin containing preparations|
|Abstract:||Disclosed are lyophilized gonadotropin containing preparations containing a dicarboxylic acid salt stabilizer. The particular proteins (e.g. LH, TSH, FSH, or HCG) are in admixture with, and at least partially capable of stabilization by, the particular stabilizer in lyophilized form. The preparations contain a sufficient amount of dicarboxylic acid salt to stabilize the protein in freeze-dried form for a desired time at a desired temperature. Typical dicarboxylic acid salts disclosed are the salts of citric, tartaric, and aspartic acids. The preparations preferably include a non-reducing disaccharide to increase the collapse temperature of the solution to be lyophilized. Methods of making the preparations in lyophilized form and the resulting injectable preparations are also disclosed.|
|Inventor(s):||de Meere; Andreas L. J. (Waspik, NL), De Ruiter; Marinus A. (Oss, NL)|
|Assignee:||Akzo N.V. (Arnhem, NL)|
1. A stabilized lyophilized FSH composition comprising:
1 part by weight FSH and
1to 10,000 parts by weight of at least one salt of an organic acid selected from the group consisting of salts or citric acid, tartaric acid, aspartic acid, isocitric acid, glutamic acid, and mixtures thereof, whereby a decrease in FSH activity over time is delayed.
2. The gonadotropin composition of claim 1, further comprising a non-reducing sugar selected from the group of sucrose and trehalose, wherein the non-reducing sugar is present in an amount of about three to fifty times by weight of the organic acid salt.
3. The composition of claim 1, wherein said composition contains sufficient organic acid salt to form a solution having an ionic strength of at least 0.05 mol/l when said composition is reconstituted with water.
4. The composition of claim 1 wherein said organic acid salt is selected from the group consisting of salts of tartaric acid, aspartic acid, isocitric acid, glutamic acid, and mixtures thereof.
5. The composition of claim 2 wherein said non-reducing sugar is trehalose.
6. The composition of claim 2, wherein the non-reducing sugar is present in an amount of about three times by weight of the organic acid salt.
7. A lyophilized FSH composition comprising:
one part by weight of a FSH, said FSH being of recombinant source; and
200 to 10,000 parts by weight of at least one salt of an organic acid selected from the group consisting of salts of citric acid, tartaric acid, aspartic acid, isocitric acid, glutamic acid and mixtures thereof.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.